JP2023509443A5 - - Google Patents
Info
- Publication number
- JP2023509443A5 JP2023509443A5 JP2022540917A JP2022540917A JP2023509443A5 JP 2023509443 A5 JP2023509443 A5 JP 2023509443A5 JP 2022540917 A JP2022540917 A JP 2022540917A JP 2022540917 A JP2022540917 A JP 2022540917A JP 2023509443 A5 JP2023509443 A5 JP 2023509443A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- optionally
- amino acid
- promoter
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962955667P | 2019-12-31 | 2019-12-31 | |
| US62/955,667 | 2019-12-31 | ||
| PCT/US2020/067664 WO2021138559A1 (en) | 2019-12-31 | 2020-12-31 | Improved aav-abcd1 constructs and use for treatment or prevention of adrenoleukodystrophy (ald) and/or adrenomyeloneuropathy (amn) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023509443A JP2023509443A (ja) | 2023-03-08 |
| JP2023509443A5 true JP2023509443A5 (cg-RX-API-DMAC7.html) | 2023-07-05 |
Family
ID=76686949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022540917A Pending JP2023509443A (ja) | 2019-12-31 | 2020-12-31 | 改善されたaav-abcd1コンストラクトならびに副腎白質ジストロフィー(ald)および/または副腎脊髄ニューロパチー(amn)の処置または予防のための使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11779655B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4085143B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023509443A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220128632A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116096904A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020416291A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022013027A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3166374A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL294278A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022008201A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021138559A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3228344A1 (en) * | 2021-08-06 | 2023-02-09 | Wuhan Neurophth Biotechnology Limited Company | Composition and method for treating leber's hereditary optic neuropathy caused by nd4 mutation |
| US20240229067A9 (en) * | 2022-05-12 | 2024-07-11 | AAVnerGene Inc. | Compositions and methods for recombinant parvovirus production |
| WO2023220502A1 (en) * | 2022-05-12 | 2023-11-16 | AAVnerGene Inc. | Compositions and methods for recombinant parvovirus production |
| EP4536862A1 (en) * | 2022-06-09 | 2025-04-16 | Wisconsin Alumni Research Foundation | Generation of next generation recombinant aav gene therapy vectors that adopt 3d conformation |
| AU2024315073A1 (en) * | 2023-07-28 | 2026-01-22 | Regeneron Pharmaceuticals, Inc. | Use of bgh-sv40l tandem polya to enhance transgene expression during unidirectional gene insertion |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| DK2359869T3 (en) | 2001-12-17 | 2019-04-15 | Univ Pennsylvania | Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof |
| EP1668143B1 (en) | 2003-09-30 | 2013-03-20 | The Trustees of The University of Pennsylvania | Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| DE23193606T1 (de) | 2005-04-07 | 2024-02-15 | The Trustees Of The University Of Pennsylvania | Verfahren zur erhöhung der funktion eines aav-vektors |
| US7588772B2 (en) | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| AU2009273239B2 (en) * | 2008-07-23 | 2015-07-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel regulatory elements |
| JP6091435B2 (ja) * | 2011-02-22 | 2017-03-08 | カリフォルニア インスティチュート オブ テクノロジー | アデノ随伴ウイルス(aav)ベクターを用いたタンパク質の送達 |
| DK2717922T3 (en) * | 2011-06-10 | 2019-01-07 | Bluebird Bio Inc | GENERATIVE VECTORS FOR ADDRENOLEUCODYSTROPHY AND ADDRENOMYELONE EUROPE |
| US9163259B2 (en) * | 2012-05-04 | 2015-10-20 | Novartis Ag | Viral vectors for the treatment of retinal dystrophy |
| EP2940131B1 (en) * | 2012-12-25 | 2019-02-20 | Takara Bio Inc. | Aav variant |
| WO2015153889A2 (en) * | 2014-04-02 | 2015-10-08 | University Of Florida Research Foundation, Incorporated | Materials and methods for the treatment of latent viral infection |
| EP3270960A4 (en) * | 2015-03-20 | 2018-08-08 | Bluebird Bio, Inc. | Vector formulations |
| EP3285788B1 (en) * | 2015-04-23 | 2024-12-18 | University of Massachusetts | Modulation of aav vector transgene expression |
| PL3370705T3 (pl) * | 2015-11-05 | 2022-08-01 | The General Hospital Corporation | Dooponowe dostarczanie sekwencji kwasów nukleinowych do kodowania abcd1 w leczeniu adrenomieloneuropatii |
| HRP20231451T1 (hr) * | 2016-02-05 | 2024-03-01 | Emory University | Ubrizgavanje jednolančanog ili samo-komplementarnog adeno-povezanog virusa 9 u cerebrospinalnu tekućinu |
| WO2017137585A1 (en) * | 2016-02-12 | 2017-08-17 | Combigene Ab | Vector |
| CN107287239B (zh) * | 2016-04-11 | 2020-09-22 | 厦门继景生物技术有限责任公司 | 一种用于视网膜色素变性的基因治疗载体及药物 |
| ES2982489T3 (es) * | 2016-08-19 | 2024-10-16 | Univ Florida | Composiciones para el tratamiento de afecciones que utilizan virus adeno-asociados recombinantes autocomplementarios |
| CA3050690A1 (en) * | 2017-01-17 | 2018-07-26 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for diagnosing and treating peroxisomal diseases |
| CN110650624A (zh) * | 2017-03-10 | 2020-01-03 | 威斯康星州医药大学股份有限公司 | 用于视网膜疾病的核糖开关调节的基因治疗 |
| US20200377887A1 (en) * | 2017-09-22 | 2020-12-03 | Voyager Therapeutics, Inc. | Compositions and methods of treating huntington's disease |
| US12201657B2 (en) * | 2017-10-18 | 2025-01-21 | City Of Hope | Adeno-associated virus compositions for restoring HBB gene function and methods of use thereof |
| GB201817470D0 (en) * | 2018-10-26 | 2018-12-12 | Univ Oxford Innovation Ltd | Gene therapy |
-
2020
- 2020-12-31 CN CN202080097613.5A patent/CN116096904A/zh active Pending
- 2020-12-31 MX MX2022008201A patent/MX2022008201A/es unknown
- 2020-12-31 IL IL294278A patent/IL294278A/en unknown
- 2020-12-31 CA CA3166374A patent/CA3166374A1/en active Pending
- 2020-12-31 BR BR112022013027A patent/BR112022013027A2/pt unknown
- 2020-12-31 EP EP20909162.8A patent/EP4085143B1/en active Active
- 2020-12-31 WO PCT/US2020/067664 patent/WO2021138559A1/en not_active Ceased
- 2020-12-31 JP JP2022540917A patent/JP2023509443A/ja active Pending
- 2020-12-31 AU AU2020416291A patent/AU2020416291A1/en not_active Abandoned
- 2020-12-31 KR KR1020227026264A patent/KR20220128632A/ko not_active Ceased
-
2021
- 2021-12-21 US US17/557,409 patent/US11779655B2/en active Active
-
2023
- 2023-08-30 US US18/458,665 patent/US20240009326A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Büeler | Adeno-associated viral vectors for gene transfer and gene therapy | |
| US6365403B1 (en) | High-efficiency AAV helper functions | |
| JP2022549380A5 (cg-RX-API-DMAC7.html) | ||
| JP2022535749A5 (cg-RX-API-DMAC7.html) | ||
| AU2018207259A1 (en) | Polynucleotides and vectors for the expression of transgenes | |
| US12077772B2 (en) | Transgene cassettes, AAV vectors and AAV viral vectors for the expression of human codon-optimized SLC6A1 | |
| AU2001279198A1 (en) | Helper functions for recombinant vector production | |
| WO2004020600A2 (en) | Modified aav | |
| WO2001036623A2 (en) | Ecdysone-inducible adeno-associated virus expression vectors | |
| WO2020142714A1 (en) | Aav expression cassette and aav vectors comprising the same | |
| AU2023378899A1 (en) | Gene therapy for frontotemporal dementia | |
| WO2021113634A1 (en) | Transgene cassettes designed to express a human mecp2 gene | |
| CN120548368A (zh) | 用于正确包装重复元件的腺相关病毒载体 | |
| JP2023542241A5 (cg-RX-API-DMAC7.html) | ||
| AU2021255934A1 (en) | Compositions and methods for treatment of neurological disorders | |
| US20260131024A1 (en) | Gene therapy for prader willi syndrome | |
| JP2025515030A5 (cg-RX-API-DMAC7.html) | ||
| WO2023056367A1 (en) | Slc13a5 gene therapy vectors and uses thereof | |
| WO2023111106A1 (en) | Fukutin related protein gene transfer increase using modified itr sequences | |
| WO2022169861A2 (en) | Gene therapy for angelman syndrome | |
| CN117836312A (zh) | 分离的修饰的aav9衣壳蛋白vp1 | |
| US12480098B1 (en) | Adeno-associated virus variant | |
| WO2025162449A1 (en) | Compositions and methods for the treatment of heart disease | |
| CN118955653A (zh) | 腺相关病毒衣壳蛋白的突变体、编码其的核酸及应用 | |
| HK40128602A (en) | Improved recombinant polyadenylation signal sequences and use thereof |